| scholarly article | Q13442814 |
| P50 | author | Francisco M. Marty | Q43126104 |
| Sophia Koo | Q48052401 | ||
| Joseph H Antin | Q89778009 | ||
| Lindsey R Baden | Q92950866 | ||
| P2093 | author name string | Edwin P Alyea | |
| Robert J Soiffer | |||
| John Koreth | |||
| Philippe Armand | |||
| Vincent T Ho | |||
| Corey S Cutler | |||
| Nicolas C Issa | |||
| Lisa S Gagne | |||
| Kelly A Verrill | |||
| P2860 | cites work | Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis | Q30227428 |
| Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. | Q30380575 | ||
| Response to a monovalent 2009 influenza A (H1N1) vaccine. | Q30380581 | ||
| Mechanism of action of rituximab | Q34192294 | ||
| Influenza vaccination in hematopoietic SCT recipients | Q37251090 | ||
| The benefit of influenza vaccination after bone marrow transplantation | Q39199964 | ||
| 2009 H1N1 influenza infection in cancer patients and hematopoietic stem cell transplant recipients. | Q40366829 | ||
| Influenza immunization: serologic and clinical responses in military units | Q43207532 | ||
| Granulocyte-macrophage colony-stimulating factor as immunomodulating factor together with influenza vaccination in stem cell transplant patients | Q44060659 | ||
| Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy | Q45115470 | ||
| Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. | Q45729513 | ||
| Community respiratory virus infections in bone marrow transplant recipients: the M.D. Anderson Cancer Center experience | Q45734202 | ||
| Respiratory virus infections in stem cell transplant patients: the European experience | Q45734204 | ||
| Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation | Q45735386 | ||
| Respiratory virus infections in bone marrow transplant recipients: the European perspective | Q45741856 | ||
| Respiratory virus infections after marrow transplant: the Fred Hutchinson Cancer Research Center experience | Q45741859 | ||
| Influenza A virus infections among hospitalized adult bone marrow transplant recipients. | Q45781442 | ||
| Evaluation of Immune Responses to Seasonal Influenza Vaccination in Healthy Volunteers and in Patients After Stem Cell Transplantation | Q58789095 | ||
| Serological response to influenza vaccine after hematopoetic stem cell transplantation | Q61771597 | ||
| Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-depleted and autologous BMT recipients | Q70557635 | ||
| Vaccination of patients with haematological malignancies with one or two doses of influenza vaccine: a randomised study | Q81896225 | ||
| P433 | issue | 3 | |
| P921 | main subject | influenza A virus | Q834390 |
| P304 | page(s) | 434-438 | |
| P577 | publication date | 2010-10-13 | |
| P1433 | published in | Biology of Blood and Marrow Transplantation | Q15754328 |
| P1476 | title | Seroprotective titers against 2009 H1N1 influenza A virus after vaccination in allogeneic hematopoietic stem cell transplantation recipients | |
| P478 | volume | 17 |
| Q90566983 | A comparison of viral microneutralization and haemagglutination inhibition assays as measures of seasonal inactivated influenza vaccine immunogenicity in the first year after reduced intensity conditioning, lymphocyte depleted allogeneic haematopoie |
| Q40306881 | A pilot randomized trial of adjuvanted influenza vaccine in adult allogeneic hematopoietic stem cell transplant recipients. |
| Q30413413 | A prospective study of the factors shaping antibody responses to the AS03-adjuvanted influenza A/H1N1 vaccine in cancer outpatients |
| Q36781782 | A randomized trial of one versus two doses of influenza vaccine after allogeneic transplantation |
| Q30356737 | Comparable humoral response after two doses of adjuvanted influenza A/H1N1pdm2009 vaccine or natural infection in allogeneic stem cell transplant recipients. |
| Q44302778 | Durable immune response to inactivated H1N1 vaccine is less likely in children with sickle cell anemia receiving chronic transfusions |
| Q38077827 | European guidelines for prevention and management of influenza in hematopoietic stem cell transplantation and leukemia patients: summary of ECIL-4 (2011), on behalf of ECIL, a joint venture of EBMT, EORTC, ICHS, and ELN. |
| Q30424791 | Evaluation of 2009 pandemic H1N1 influenza vaccination in adults with lymphoid malignancies receiving chemotherapy or following autologous stem cell transplant. |
| Q35018548 | Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients |
| Q30400161 | Immune response to pandemic H1N1 2009 influenza a vaccination in pediatric liver transplant recipients |
| Q30373149 | Immunogenicity of virosomal adjuvanted trivalent influenza vaccination in allogeneic stem cell transplant recipients. |
| Q28740919 | Influenza vaccination for immunocompromised patients: systematic review and meta-analysis from a public health policy perspective |
| Q30358640 | Influenza vaccination in immunocompromised patients: efficacy and safety. |
| Q37940524 | Influenza vaccination in the organ transplant recipient: review and summary recommendations. |
| Q24202869 | Influenza vaccines in immunosuppressed adults with cancer |
| Q49500210 | Influenza vaccines in immunosuppressed adults with cancer |
| Q35846308 | Longitudinal analysis of tetanus- and influenza-specific IgG antibodies in myeloma patients |
| Q30418951 | Outbreak of pandemic 2009 influenza A/H1N1 infection in the hematology ward: fatal clinical outcome of hematopoietic stem cell transplant recipients and emergence of the H275Y neuraminidase mutation |
| Q30412678 | Perspective: emerging challenges in the treatment of influenza and parainfluenza in transplant patients |
| Q60958294 | Respiratory Viral Infections in Patients With Cancer or Undergoing Hematopoietic Cell Transplant |
| Q90747088 | Respiratory viral infections post-lung transplantation |
| Q36846282 | Safety and immunogenicity of modified vaccinia Ankara in hematopoietic stem cell transplant recipients: a randomized, controlled trial. |
| Q36009655 | Screening and Monitoring for Infectious Complications When Immunosuppressive Agents Are Studied in the Treatment of Autoimmune Disorders |
| Q40413531 | Serum IgM levels independently predict immune response to influenza vaccine in long-term survivors vaccinated at >1 year after undergoing allogeneic hematopoietic stem cell transplantation |
| Q41136482 | Significant Transplantation-Related Mortality from Respiratory Virus Infections within the First One Hundred Days in Children after Hematopoietic Stem Cell Transplantation |
| Q30409959 | The antibody response to pandemic H1N1 2009 influenza vaccine in adult organ transplant patients |
| Q33409067 | The effect of rituximab on vaccine responses in patients with immune thrombocytopenia |
| Q30398382 | The humoral immune response of hematopoietic stem cell transplantation recipients to AS03-adjuvanted A/California/7/2009 (H1N1)v-like virus vaccine during the 2009 pandemic |
| Q30408740 | Vaccination against pandemic H1N1 (2009) in patients after allogeneic hematopoietic stem cell transplantation: a retrospective analysis. |
| Q42224597 | Vaccination for seasonal influenza in patients with cancer: recommendations of the Italian Society of Medical Oncology (AIOM). |
| Q91465246 | Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7) |
Search more.